Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onder Alpdogan

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2020
Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on OutcomesDolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantationGabrielle L Goldberg, Onder Alpdogan, Stephanie J Muriglan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantationMiguel-Angel Perales, Adi Diab, Adam D Cohen, et al.
Blood|October 8, 2008
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host diseaseSydney X Lu, Onder Alpdogan, Janine Lin, et al.
Blood Advances|April 26, 2022
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2Kerry J Savage, Steven M Horwitz, Ranjana Advani, et al.
Blood|November 18, 2008
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantationRobert R Jenq, Christopher G King, Christine Volk, et al.
Blood Advances|August 19, 2025
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell LymphomaSwaminathan P Iyer, Neha Mehta-Shah, Ranjana H Advani, et al.
Nature Medicine|August 29, 2006
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantationJohannes L Zakrzewski, Adam A Kochman, Sydney X Lu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2010
Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host diseaseSydney X Lu, Amanda M Holland, Il-Kang Na, et al.
Plos One|July 16, 2011
Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantationSydney X Lu, Lucy W Kappel, Anne-Marie Charbonneau-Allard, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2020
Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on OutcomesDolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantationGabrielle L Goldberg, Onder Alpdogan, Stephanie J Muriglan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantationMiguel-Angel Perales, Adi Diab, Adam D Cohen, et al.
Blood|October 8, 2008
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host diseaseSydney X Lu, Onder Alpdogan, Janine Lin, et al.
Blood Advances|April 26, 2022
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2Kerry J Savage, Steven M Horwitz, Ranjana Advani, et al.
Blood|November 18, 2008
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantationRobert R Jenq, Christopher G King, Christine Volk, et al.
Blood Advances|August 19, 2025
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell LymphomaSwaminathan P Iyer, Neha Mehta-Shah, Ranjana H Advani, et al.
Nature Medicine|August 29, 2006
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantationJohannes L Zakrzewski, Adam A Kochman, Sydney X Lu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2010
Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host diseaseSydney X Lu, Amanda M Holland, Il-Kang Na, et al.
Plos One|July 16, 2011
Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantationSydney X Lu, Lucy W Kappel, Anne-Marie Charbonneau-Allard, et al.
Pageof 9